Company profile for Modis Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ringing disease-modifying therapies to patients with rare genetic diseases Modis Therapeutics was formed in 2016 through a collaboration with academic experts in mitochondrial biology to develop disease-modifying therapies for rare genetic diseases. We completed a series A financing in March of 2018 with investments from F-Prime Capital Partners, OrbiMed, Aceras Life Sciences, and Osage University Partners. The company has ass...
Ringing disease-modifying therapies to patients with rare genetic diseases Modis Therapeutics was formed in 2016 through a collaboration with academic experts in mitochondrial biology to develop disease-modifying therapies for rare genetic diseases. We completed a series A financing in March of 2018 with investments from F-Prime Capital Partners, OrbiMed, Aceras Life Sciences, and Osage University Partners. The company has assembled a management team with deep experience in the development of high-impact products for serious diseases at leading biotech and pharmaceutical companies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
409 13th Street, Suite 700 Oakland, CA 94612
Telephone
Telephone
1-510-806-8562
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biopharmadive.com/news/zogenix-buys-modis-for-250m-building-out-rare-disease-pipeline/561681/

Andrew Dunn BIOPHARMADIVE
27 Aug 2019

ABOUT THIS PAGE

Contact Modis Therapeutics and get a quotation

Modis Therapeutics is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of MT1621 DRUG PRODUCT bulk offered by Modis Therapeutics

Find a price of MT1621 (DRUG SUBSTANCE) bulk offered by Modis Therapeutics

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty